Printer Friendly

NORTH AMERICAN BIOLOGICALS, INC. EXPANDS MANAGEMENT TEAM; APPOINTS PINYA COHEN FROM NIH AND GEORGE BINGHAM FROM BAXTER

 NORTH AMERICAN BIOLOGICALS, INC. EXPANDS MANAGEMENT TEAM;
 APPOINTS PINYA COHEN FROM NIH AND GEORGE BINGHAM FROM BAXTER
 MIAMI, Aug. 13 /PRNewswire/ -- North American Biologicals, Inc. ("NABI") (NASDAQ: NBIO) today announced it has appointed Pinya Cohen, Ph.D., formerly of the Food and Drug Administration (FDA) and the National Institutes of Health (NIH), as vice president, quality assurance and regulatory affairs, and George D. Bingham, formerly of Baxter Healthcare, as general manager, Immune Globulin Division. Both positions are newly created at NABI, and reflect the company's strategic expansion in proprietary plasma-based products.
 Dr. Cohen joins NABI following more than 20 years' experience in regulatory affairs, including eight years with the NIH as chief, Blood and Blood Derivatives Section, four years at the FDA's Bureau of Biologics as director, Plasma Derivatives Branch, and 16 years as vice president, regulatory affairs, with Pasteur Merieux and Connaught. Dr. Cohen received his Ph.D. in microbiology from Purdue University and his M.S. from the University of Georgia.
 Bingham's background includes more than 14 years at Baxter Healthcare Corporation, where he served most recently as manager, quality circle administration, Baxter Diagnostics, Inc. He received his M.B.A. from the University of Miami and his B.S. in engineering at the University of Tennessee.
 "Part of NABI's strategy for growth is to expand our portfolio of new proprietary plasma-based products. Immune globulin products, for example, have significant potential to be a major source of growth for the company. The skills that these two individuals bring to the firm enhance our ability to identify, develop and market such products effectively, and we are very pleased to have Dr. Cohen and Mr. Bingham on our management team," said David J. Gury, NABI's chairman, president and CEO.
 North American Biologicals, Inc., headquartered in Miami, is the world's largest independent provider of human blood plasma elements to the health care industry, one of the largest AIDS screening laboratories in the United States, and a leading supplier of control products used to ensure accuracy in blood testing laboratories.
 -0- 8/13/92
 /CONTACT: David J. Gury, president, or Alfred J. Fernandez, vice president-finance, North American Biologicals, Inc., 305-628-0080; or Lori E. Martin of Feinstein Partners, 617-577-8110, for North American Biologicals, Inc./
 (NBIO) CO: North American Biologicals, Inc. ST: Florida IN: MTC SU: PER


DH -- NE010 -- 9642 08/13/92 12:38 EDT
COPYRIGHT 1992 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1992 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Aug 13, 1992
Words:392
Previous Article:SPRINT PROMOTES DISCOUNT CALLING PLAN WITH CELEBRITY CUTOUTS, FREE PHONE CALLS AT MALLS NATIONWIDE
Next Article:THE BOSTON FIVE REPORTS MORTGAGE PRODUCTION TOTALS
Topics:


Related Articles
NORTH AMERICAN BIOLOGICALS EXPANDS MANAGEMENT TEAM WITH THREE NEW EXECUTIVES
BAXTER ENLISTS TRAMMELL CROW, NORTH AMERICAN PAPER IN HELPING HOSPITALS CUT COSTS
NORTH AMERICAN BIOLOGICALS TO ACQUIRE MAJOR PLASMA COMPANY
NORTH AMERICAN BIOLOGICALS COMPLETES ACQUISITION OF MAJOR PLASMA COMPANY
NORTH AMERICAN BIOLOGICALS, INC. AND UNIVAX BIOLOGICS, INC. ANNOUNCE AGREEMENT TO MERGE IN $150+ MILLION TRANSACTION
NORTH AMERICAN BIOLOGICALS, INC. AND UNIVAX BIOLOGICS, INC. COMPLETE MERGER, CREATING NEW FIRST-TIER BIOPHARMACEUTICAL COMPANY
PERSEPTIVE BIOSYSTEMS CREATES NEW EXECUTIVE POST
AT CLOSING PEOPLE.
Insurance Broker Kaye Group Names New President, CEO; Marc Cohen to Succeed Bruce Guthart, Who Moves to Parent COO Position.
William Lyons, Former President and CEO of American Century Companies, Inc., Joins Morningstar's Board of Directors.

Terms of use | Copyright © 2017 Farlex, Inc. | Feedback | For webmasters